Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Clinical innovation and scientific progress in GLP-1 medicine (Nov 2025)
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Target organ localization of memory CD4+ T cells in patients with chronic beryllium disease
Andrew P. Fontenot, Scott J. Canavera, Laia Gharavi, Lee S. Newman, Brian L. Kotzin
Andrew P. Fontenot, Scott J. Canavera, Laia Gharavi, Lee S. Newman, Brian L. Kotzin
View: Text | PDF
Article Aging

Target organ localization of memory CD4+ T cells in patients with chronic beryllium disease

  • Text
  • PDF
Abstract

Research Article

Authors

Andrew P. Fontenot, Scott J. Canavera, Laia Gharavi, Lee S. Newman, Brian L. Kotzin

×

Figure 7

Options: View larger image (or click on image) Download as PowerPoint
Surface markers expressed by BAL CD4+ T cells from CBD patients. (a) The...
Surface markers expressed by BAL CD4+ T cells from CBD patients. (a) The percentage of BAL CD4+ T cells that express CD45RO, CD62L, CD11a, and CCR7 is shown. The symbols for each CBD patient correspond to those shown in Figures 4 and 6, and the solid line represents the mean value for each marker. (b) Intracellular IFN-γ production by BAL CD4+ T cells in relation to expression of CCR7 following stimulation with medium alone or SEB. Data are shown for the percentage of BAL CD4+ T cells that express IFN-γ, CCR7, or both. (c) IFN-γ and IL-2 production by BAL CD4+ T cells in relation to expression of CCR7 following stimulation with BeSO4. Data are shown for the percentage of BAL CD4+ T cells that express IFN-γ, CCR7, or both.

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts